Psychedelics for Mental Health: Help or Hype?
Open to Debate
00:00
Intro
This chapter explores the ongoing debate over the potential reclassification of psychedelic substances for medicinal use, particularly in treating conditions like depression and PTSD. It discusses recent FDA developments regarding MDMA and emphasizes the need for further research to evaluate the benefits and risks of these substances in mental health treatment.
Transcript
Play full episode
